Skip to main content
OpenTrials

Clinical trial condition

Lysosomal Storage Diseases

Explore clinical trials studying Lysosomal Storage Diseases. Study availability and eligibility vary by location and protocol.

710 public trials 130 recruiting studies
Refine in advanced search Browse all conditions

Lysosomal Storage Diseases trial results

Completed

Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II)

NCT01822184

Conditions
Carbohydrate Metabolism, Inborn Errors, Cognition Disorders, Cognitive Dysfunction, +25 more
Locations
  • Childrens Hospital & Research Center Oakland Oakland, California, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • University of North Carolina Division of Genetics and Metabolism Chapel Hill, North Carolina, United States
  • Hospital Universitario Austral Pilar, Buenos Aires, Argentina
View Trial Details
Completed

Long-term Outcome in Late-onset Pompe Disease Treated Beyond 36 Months (STIG-Pompe-Study)

NCT02824068

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • Friedrich-Baur-Institute, Dep. of Neurology Klinikum der Universitaet Muenchen Munich, Germany Munich, Bavaria, Germany
  • 5. Department of Clinical and Experimental Medicine, Reference Center for Rare Neuromuscular Disorders, University of Messina, Italy Messina, Sicily, Italy
  • National Taiwan University Hospital Taipei Taipei, Taiwan
View Trial Details
Completed

CARbon Impact of aNesthesic Gas

NCT04163848

Conditions
Anesthesia, Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
Locations
  • Hôpital Maisonneuve-Rosemont, CIUSSS de l'Est de l'Ile de Montréal Montreal, Quebec, Canada
View Trial Details
Completed

Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease

NCT02194985

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Clinical Study Site Atlanta, Georgia, United States
  • Clinical Study Site Kansas City, Kansas, United States
  • Clinical Study Site Grand Rapids, Michigan, United States
  • Clinical Study Site New York, United States
View all 28 locations
View Trial Details
Completed

Evaluation of Long-term Efficacy of Treatment With Lamazym

NCT02478840

Conditions
Alpha-Mannosidosis, Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +7 more
Locations
  • Center for Metabolic Diseases, Department of Clinical Genetics, Juliane Marie Centre, Copenhagen University Hospital, Blegdamsvej 9 Copenhagen, Denmark
View Trial Details

Related conditions